<DOC>
	<DOCNO>NCT03098186</DOCNO>
	<brief_summary>Purpose trial : To evaluate efficacy safety intervention SMS message deliver mobile phone improve adherence cardiovascular medication patient atherosclerotic cardiovascular disease ( ASCVD ) . Trial design : Two-parallel arm , single-blind , individually randomize control trial . Primary endpoint : Differences change ( baseline minus 12 month ) : Low density lipoprotein cholesterol ( LDL-C ) , Systolic Blood pressure Heart Rate . Secondary endpoint : Differences change ( baseline minus 12-months ) : ( ) adherence cardiovascular medication use secondary prevention measure MARS-5 questionnaire ; ( ii ) Urinary level 11 dh-TxB2 , Rates composite end-point cardiovascular death hospitalization due cardiovascular disease 12 month , Rates composite non-cardiovascular death hospitalization due non-cardiovascular disease 12 month Adverse event : traffic accident injury read SMS related trial . Duration follow-up : 12 month Trial treatment : Intervention : The active treatment consist SMS aim modified behavioral factor associate poor adherence cardiovascular medication use secondary prevention . The SMS deliver daily first month , increase one day interval week second month , weekly thereafter end month 12th . In addition , receive SMS thank participation trial , reminder trial appointment inform change contact detail . The frequency SMS monthly . Control : participant receive SMS thank participation trial , reminder trial appointment inform change contact detail . The frequency SMS monthly . Expected sample size , enrollment expect number center : Sample size = 1600 Recruitment start date : March , 2017 Recruitment end date : September , 2017 Follow-up end date : March , 2018 Number center : 1 Statistical consideration : - Intention treat analysis - The trial &gt; 90 % power ( 2 side alpha= 0.05 ) detect reduction LDL-C low 5.1 mg/dl , assumption SMS increase adherence statins 7 % . - The primary outcome analyze use ANCOVA . Partially Financed COLCIENCIAS Code : 656672553352</brief_summary>
	<brief_title>TXT2HEART COLOMBIA : Evaluation Efficacy Safety Text Messages Improve Adherence Cardiovascular Medications Secondary Prevention</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Age â‰¥18 year old History least one follow arterial occlusive event : acute coronary syndrome ( unstable angina , acute myocardial infarction without ST elevation ) , stable angina , ischemic cerebrovascular disease , peripheral arterial disease coronary revascularization ( coronary artery bypass surgery ( CABG ) percutaneous transluminal coronary angioplasty ( PTCA ) . Own least one mobile phone Ability read understand text message ( SMS ) Intention stay country recruitment next 12 month Contraindication take cardiovascular medication use secondary prevention . Participation another randomize clinical trial could interfere adherence treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Medication adherence</keyword>
	<keyword>mHealth</keyword>
</DOC>